FN1 and graft versus host disease: They promote wound healing via growth factors like EGF, vitamin A, TGF-beta, and fibronectin, lubricate the ocular surface, lower ocular surface inflammation levels, and are frequently being used to treat patients with severe chronic ocular graft versus host disease and have been shown to be both successful and safe in this entity [17, 18].